Hugo Hilton

Hugo Hilton is a seasoned professional with a deep expertise in building and launching companies in the fields of immunology and immunotherapy.

He collaborates closely with academics, clinicians, and entrepreneurs to leverage emerging technologies and drive the development of transformative medicines for patients.

Hugo holds a Doctor of Philosophy (PhD) in Immunology and Immunogenetics from The University of Edinburgh, showcasing his strong educational background.

Additionally, he has studied Veterinary Medicine at both the University of Oslo and The University of Edinburgh, further augmenting his broad knowledge base.

Hugo has held key positions in reputable organizations, currently serving as Principal at Third Rock Ventures.

Prior to his current role, he was a Senior Associate at Third Rock Ventures, underlining his progressive career trajectory.

His experience includes roles such as Senior Scientist II at Maze Therapeutics, Scientist at Calico Life Sciences, and Research Scientist at Stanford University.

Furthermore, Hugo's academic journey includes being a Post-Doctoral Fellow at Stanford University and a Research Assistant at UC Davis.

His expertise extends to the field of Veterinary Medicine, with experiences such as being a Resident in Equine Internal Medicine at UC Davis and completing a Large Animal Medicine Fellowship at the University of Guelph.